~~<i id='CD3586523E'><strike id='CD3586523E'><tt id='CD3586523E'><pre id='CD3586523E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

explore

author：comprehensive 2025-09-05 09:13:24 - browse：521

Trump Campaign Event In Nevada — Ethan Miller/Getty Images

WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Kenai launches with $82 million for Parkinson’s stem cell therapy

focus

explore

hotspot

focus

explore

ANorthwellHealthregisterednursefillsasyringewiththeJohnson&JohnsonCovid-19vaccineatapop-upvaccin

WSS

Pfizer highlights cancer drugs it thinks could reignite investor interest

Change Healthcare cyberattack outage could last weeks

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Test for long Covid? Researchers find new clue in blood samples

In search for therapies for solid tumors, companies turn to claudin

Parkinson’s finding may lead to tests and, someday, treatments

focus

explore

focus

Activists slam private health insurers over coverage restrictions

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Eli Lilly, Pfizer, and others want in on the online prescription market

BioMarin wins approval for gene therapy to treat hemophilia A

Test for long Covid? Researchers find new clue in blood samples

Drug repurposing or repositioning? The language matters

Pfizer highlights cancer drugs it thinks could reignite investor interest

Malaria cases in Florida and Texas: Here’s what you need to know

Medicare Advantage today, explained in one chart

explore

Prior authorization will have to move faster under new Biden rule

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Clinical trials giant ICON acquires HumanFirst

Change Healthcare cyberattack outage could last weeks

Independent physicians launch a new lobbying group

Flu vaccine offering decent levels of protection this winter, new data show

hotspot

focus

explore

explore